These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36831011)

  • 1. Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism.
    Li H; Li JJ; Lu W; Yang J; Xia Y; Huang P
    Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
    He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
    Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
    Qiao S; Lu W; Glorieux C; Li J; Zeng P; Meng N; Zhang H; Wen S; Huang P
    Oncogene; 2021 Sep; 40(39):5880-5892. PubMed ID: 34349242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallic acid induces apoptosis and enhances the anticancer effects of cisplatin in human small cell lung cancer H446 cell line via the ROS-dependent mitochondrial apoptotic pathway.
    Wang R; Ma L; Weng D; Yao J; Liu X; Jin F
    Oncol Rep; 2016 May; 35(5):3075-83. PubMed ID: 26987028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy.
    Zeng P; Lu W; Tian J; Qiao S; Li J; Glorieux C; Wen S; Zhang H; Li Y; Huang P
    J Hematol Oncol; 2022 Mar; 15(1):30. PubMed ID: 35313945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis.
    Shi F; He Y; Li J; Tang M; Li Y; Xie L; Zhao L; Hu J; Luo X; Zhou M; Liu N; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Jia W; Bode AM; Cao Y
    Mol Metab; 2020 Jun; 36():100966. PubMed ID: 32224436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation.
    Li S; Chou AP; Chen W; Chen R; Deng Y; Phillips HS; Selfridge J; Zurayk M; Lou JJ; Everson RG; Wu KC; Faull KF; Cloughesy T; Liau LM; Lai A
    Neuro Oncol; 2013 Jan; 15(1):57-68. PubMed ID: 23115158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial NADP
    Kong MJ; Han SJ; Kim JI; Park JW; Park KM
    Cell Death Dis; 2018 May; 9(5):488. PubMed ID: 29695796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High levels of EGFR prevent sulforaphane-induced reactive oxygen species-mediated apoptosis in non-small-cell lung cancer cells.
    Wang TH; Chen CC; Huang KY; Shih YM; Chen CY
    Phytomedicine; 2019 Nov; 64():152926. PubMed ID: 31454652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
    Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
    Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS/pAKT signalling.
    Chen X; Zhuo S; Xu W; Chen X; Huang D; Sun X; Cheng Y
    Br J Cancer; 2020 Jul; 123(1):126-136. PubMed ID: 32367071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of the mitochondria-targeted antioxidant MitoQ in mitochondrial-ROS induced sensorineural hearing loss caused by Idh2 deficiency.
    Kim YR; Baek JI; Kim SH; Kim MA; Lee B; Ryu N; Kim KH; Choi DG; Kim HM; Murphy MP; Macpherson G; Choo YS; Bok J; Lee KY; Park JW; Kim UK
    Redox Biol; 2019 Jan; 20():544-555. PubMed ID: 30508699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function.
    Dong J; Zhu D; Chen M; Wang T; Gao Y; Liu W
    Thorac Cancer; 2022 May; 13(10):1513-1524. PubMed ID: 35429141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH2 knockdown sensitizes tumor cells to emodin cytotoxicity in vitro and in vivo.
    Ku HJ; Kwon OS; Kang BS; Lee DS; Lee HS; Park JW
    Free Radic Res; 2016 Oct; 50(10):1089-1097. PubMed ID: 27087448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species-mediated senescence is accelerated by inhibiting Cdk2 in Idh2-deficient conditions.
    Chae U; Park JW; Lee SR; Lee HJ; Lee HS; Lee DS
    Aging (Albany NY); 2019 Sep; 11(17):7242-7256. PubMed ID: 31503005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1α
    Wang Y; Agarwal E; Bertolini I; Ghosh JC; Seo JH; Altieri DC
    FASEB J; 2019 Dec; 33(12):13398-13411. PubMed ID: 31530011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isocitrate dehydrogenase 2 deficiency induces endothelial inflammation via p66sh-mediated mitochondrial oxidative stress.
    Choi SJ; Piao S; Nagar H; Jung SB; Kim S; Lee I; Kim SM; Song HJ; Shin N; Kim DW; Irani K; Jeon BH; Park JW; Kim CS
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1805-1811. PubMed ID: 30072100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
    Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P
    Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.